ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 161 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,843,260 | +16.0% | 898,000 | 0.0% | 0.30% | +7.1% |
| Q1 2023 | $15,382,740 | +67.0% | 898,000 | +90.8% | 0.28% | +54.9% |
| Q4 2022 | $9,210,699 | -74.0% | 470,654 | -69.6% | 0.18% | -73.8% |
| Q3 2020 | $35,433,000 | +9.2% | 1,550,000 | 0.0% | 0.69% | -1.6% |
| Q2 2020 | $32,442,000 | +64.4% | 1,550,000 | +9.5% | 0.70% | +10.3% |
| Q1 2020 | $19,739,000 | -38.7% | 1,415,000 | 0.0% | 0.64% | -29.5% |
| Q4 2019 | $32,205,000 | +95.4% | 1,415,000 | 0.0% | 0.91% | +66.4% |
| Q3 2019 | $16,485,000 | +10.5% | 1,415,000 | +42.3% | 0.54% | +20.3% |
| Q2 2019 | $14,915,000 | +20.0% | 994,314 | +40.3% | 0.45% | +5.8% |
| Q1 2019 | $12,429,000 | +18.4% | 708,600 | 0.0% | 0.43% | -8.0% |
| Q4 2018 | $10,501,000 | +8.1% | 708,600 | +79.6% | 0.46% | +30.3% |
| Q3 2018 | $9,715,000 | +25.4% | 394,585 | 0.0% | 0.36% | +11.2% |
| Q2 2018 | $7,746,000 | +4.7% | 394,585 | 0.0% | 0.32% | -7.2% |
| Q1 2018 | $7,398,000 | – | 394,585 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 630,380 | $12,525,651 | 16.55% |
| RTW INVESTMENTS, LP | 17,687,772 | $351,456,030 | 6.69% |
| ACUTA CAPITAL PARTNERS, LLC | 306,194 | $6,084,075 | 4.12% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,349,469 | 2.02% |
| MAVERICK CAPITAL LTD | 4,379,970 | $87,030,004 | 1.86% |
| COWEN AND COMPANY, LLC | 1,100,000 | $21,857,000 | 1.81% |
| Novo Holdings A/S | 920,000 | $18,280,400 | 1.41% |
| Boxer Capital, LLC | 1,466,051 | $29,130 | 1.35% |
| Cormorant Asset Management, LP | 868,550 | $17,258,089 | 0.97% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 156,000 | $3,093,480 | 0.94% |